MostaghimiAGaoWRayM, et al. Trends in prevalence and incidence of alopecia areata, alopecia totalis, and alopecia universalis among adults and children in a US employer-sponsored insured population. JAMA Dermatol. 2023;159(4):411. doi:10.1001/jamadermatol.2023.0002
2.
BarkerTHStoneJCSearsK, et al. Revising the JBI quantitative critical appraisal tools to improve their applicability: an overview of methods and the development process. JBI Evid Synth. 2023;21(3):478-493. doi:10.11124/JBIES-22-00125
3.
Waśkiel-BurnatAOsińskaMSalińskaA, et al. The role of serum Th1, Th2, and Th17 cytokines in patients with alopecia areata: clinical implications. Cells. 2021;10(12):3397. doi:10.3390/cells10123397
4.
LySManjalyPKamalK, et al. Comorbid conditions associated with alopecia areata: a systematic review and meta-analysis. Am J Clin Dermatol. 2023;24(6):875-893. doi:10.1007/s40257-023-00805-4
5.
LauronSPlasseCVayssetM, et al. Prevalence and odds of depressive and anxiety disorders and symptoms in children and adults with alopecia areata: a systematic review and meta-analysis. JAMA Dermatol. 2023;159(3):281-288. doi:10.1001/jamadermatol.2022.6085
